Safety, Pharmacokinetics, Pharmacodynamics, and Clinical Activity Study in VLBW Neonates of BSYX-A110

Clinical trial NCT00631800 · COMPLETED

Trial details

NCT number: NCT00631800
Sponsor: Biosynexus Incorporated
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Staphylococcal Sepsis

Start date: 2003-05-01
Primary completion: 2004-03-01
Enrollment: 88

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.